Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET

NeuroImage

Volumn 50, Issue 3, 2010, Pages 855-861

  Marner, Lisbeth ^a   Gillings, Nic ^a   Madsen, Karine ^a   Erritzoe, David ^a   Baaré, William F C ^a,b   Svarer, Claus ^a   Hasselbalch, Steen G ^a   Knudsen, Gitte M ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Citalopram; Positron emission tomography; SSRI; Test retest

Indexed keywords

8 AMINO 7 CHLORO (N METHYL 4 PIPERIDYLMETHYL) 1,4 BENZODIOXAN 5 CARBOXYLATE C 11; CITALOPRAM; RADIOLIGAND; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOPSY; BINDING AFFINITY; BRAIN REGION; BRAIN TISSUE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIGAND BINDING; MALE; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RADIOASSAY; SEX DIFFERENCE; TISSUE SPECIFICITY;

ADULT; AGING; BRAIN; BRAIN MAPPING; CITALOPRAM; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 77249125796     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.01.054     Document Type: Article

References (36)

1. Adams K.H., Pinborg L.H., Svarer C., Hasselbalch S.G., Holm S., Haugbol S., Madsen K., Frokjaer V., Martiny L., Paulson O.B., and Knudsen G.M. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. NeuroImage 21 (2004) 1105-1113
2. Arakawa R., Ito H., Takano A., Takahashi H., Morimoto T., Sassa T., Ohta K., Kato M., Okubo Y., and Suhara T. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia. Psychopharmacology (Berl) 197 (2008) 229-235
3. Bonaventure P., Hall H., Gommeren W., Cras P., Langlois X., Jurzak M., and Leysen J.E. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain. Synapse 36 (2000) 35-46
4. Cho S., and Hu Y. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival. Exp. Neurol. 203 (2007) 274-278
5. Compan V., Daszuta A., Salin P., Sebben M., Bockaert J., and Dumuis A. Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur. J. Neurosci. 8 (1996) 2591-2598
6. Compan V., Zhou M., Grailhe R., Gazzara R.A., Martin R., Gingrich J., Dumuis A., Brunner D., Bockaert J., and Hen R. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J. Neurosci. 24 (2004) 412-419
7. Cooper M.A., McIntyre K.E., and Huhman K.L. Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat. Psychoneuroendocrinology 33 (2008) 1236-1247
8. Fagni L., Dumuis A., Sebben M., and Bockaert J. The 5-HT4 receptor subtype inhibits K+current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br. J. Pharmacol. 105 (1992) 973-979
9. Gillings N., and Larsen P.A. Highly flexible modular radiochemistry system. J. Label Compd. Radiopharm. 48[(suppl)] (2005) S338 Ref Type: Abstract
10. Goldberg S., Smith G.S., Barnes A., Ma Y., Kramer E., Robeson K., Kirshner M., Pollock B.G., and Eidelberg D. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol. Aging. 25 (2004) 167-174
11. Haugbol S., Pinborg L.H., Arfan H.M., Frokjaer V.M., Madsen J., Dyrby T.B., Svarer C., and Knudsen G.M. Reproducibility of 5-HT(2A) receptor measurements and sample size estimations with [(18)F]altanserin PET using a bolus/infusion approach. Eur. J. Nucl. Med. Mol. Imaging. 34 (2007) 910-915
12. Hjorth S., Westlin D., and Bengtsson H.J. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36 (1997) 461-465
13. Holden J.E., Jivan S., Ruth T.J., and Doudet D.J. In vivo receptor assay with multiple ligand concentrations: an equilibrium approach. J. Cereb. Blood Flow Metab. 22 (2002) 1132-1141
14. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., Suhara T., Suzuki K., Innis R.B., and Carson R.E. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 23 (2003) 1096-1112
15. Jean A., Conductier G., Manrique C., Bouras C., Berta P., Hen R., Charnay Y., Bockaert J., and Compan V. Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 16335-16340
16. Jovanovic H., Lundberg J., Karlsson P., Cerin A., Saijo T., Varrone A., Halldin C., and Nordstrom A.L. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. NeuroImage 39 (2008) 1408-1419
17. King M.V., Marsden C.A., and Fone K.C. A role for the 5-HT(1A), 5-HT(4) and 5-HT(6) receptors in learning and memory. Trends Pharmacol. Sci. 29 (2008) 482-492
18. Kornum B.R., Lind N.M., Gillings N., Marner L., Andersen F., and Knudsen G.M. Evaluation of the novel 5-HT(4) receptor PET ligand [(11)C]SB207145 in the Göttingen minipig. J. Cereb. Blood Flow Metab. 29 (2009) 186-196
19. Licht C.L., Marcussen A.B., Wegener G., Overstreet D.H., Aznar S., and Knudsen G.M. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J. Neurochem. 109 (2009) 1363-1374
20. Lucas G., Rymar V.V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Pineyro G., Sadikot A.F., and Debonnel G. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55 (2007) 712-725
21. 4 receptors in the human brain in vivo. J. Nucl. Med. 50 (2009) 900-908
22. Mohler E.G., Shacham S., Noiman S., Lezoualc'h F., Robert S., Gastineau M., Rutkowski J., Marantz Y., Dumuis A., Bockaert J., Gold P.E., and Ragozzino M.E. VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 53 (2007) 563-573
23. Orsetti M., Dellarole A., Ferri S., and Ghi P. Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn. Mem. 10 (2003) 420-426
24. Ostergaard S.D., Alstrup A.K., Gramsbergen J.B., Minuzzi L., Pedersen K., Jensen S.B., Doudet D., and Cumming P. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion. Synapse 64 (2009) 70-82
25. Palego L., Marazziti D., Rossi A., Giannaccini G., Naccarato A.G., Lucacchini A., and Cassano G.B. Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus. Brain Res. 758 (1997) 26-32
26. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van H.R., Arango V., and Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 954 (2002) 173-182
27. Pinborg L.H., Adams K.H., Yndgaard S., Hasselbalch S.G., Holm S., Kristiansen H., Paulson O.B., and Knudsen G.M. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J. Cereb. Blood Flow Metab. 24 (2004) 1037-1045
28. Rabiner E.A., Messa C., Sargent P.A., Husted-Kjaer K., Montgomery A., Lawrence A.D., Bench C.J., Gunn R.N., Cowen P., and Grasby P.M. A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. NeuroImage 15 (2002) 620-632
29. Reynolds G.P., Mason S.L., Meldrum A., De K.S., Parnes H., Eglen R.M., and Wong E.H. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br. J. Pharmacol. 114 (1995) 993-998
30. Robert S.J., Zugaza J.L., Fischmeister R., Gardier A.M., and Lezoualc'h F. The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276 (2001) 44881-44888
31. Smith G.S., Ma Y., Dhawan V., Gunduz H., Carbon M., Kirshner M., Larson J., Chaly T., Belakhleff A., Kramer E., Greenwald B., Kane J.M., Laghrissi-Thode F., Pollock B.G., and Eidelber D. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 45 (2002) 105-112
32. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Holm S., Paulson O.B., and Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. NeuroImage 24 (2005) 969-979
33. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., Javanmard M., Kasper S., and Kapur S. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 24 (2001) 522-530
34. Terry Jr. A.V., Buccafusco J.J., Jackson W.J., Prendergast M.A., Fontana D.J., Wong E.H., Bonhaus D.W., Weller P., and Eglen R.M. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology (Berl) 135 (1998) 407-415
35. Turner P.R., O'Connor K., Tate W.P., and Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70 (2003) 1-32
36. Varnas K., Halldin C., Pike V.W., and Hall H. Distribution of 5-HT4 receptors in the postmortem human brain-an autoradiographic study using [125I]SB 207710. Eur. Neuropsychopharmacol. 13 (2003) 228-234